Insmed Incorporated CEO Geoffrey Allan Testifies at Energy and Commerce Committee Hearing

RICHMOND, Va.--(BUSINESS WIRE)--Insmed Inc. (Nasdaq:INSM) President and Chief Executive Officer Geoffrey Allan, Ph.D., testified today at a congressional hearing, “Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States.”